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Abstract Measures of clinical significance offer important
information about psychological interventions that cannot be
garnered from tests of the statistical significance of the change
from pretest to posttest. For example, post-intervention com-
parisons to a nonclinical group often offer valuable informa-
tion about the practical value of the change that occurred. This
study explored the manner in which researchers conduct clin-
ical significance analyses in an effort to summarize the effec-
tiveness of an intervention at the group level. The focus was
on the use of the original Jacobson and Truax (Journal of
Consulting and Clinical Psychology, 59, 12–19, 1991) meth-
od and the normative comparisons method due to Kendall
et al. (Journal of Consulting and Clinical Psychology, 67,
285–299, 1999). The results highlight that although the
Jacobson and Truax method is routinely adopted for summa-
rizing group-level clinical significance, advanced strategies
for summarizing the results are very infrequently applied. Fur-
ther, the Kendall et al. method, which provides valuable and
distinct information regarding how the treated group is
performing relative to a normal comparison group, is rarely
adopted and even when it is it is often not conducted appro-
priately. Recommendations are provided for conducting
group-level clinical significance analyses.
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The past few decades have seen an upward trend in the im-
portance placed on understanding the practical value of an
intervention, leading to significant improvements in the appre-
ciation of the relative benefit of different forms of interven-
tion. The practical value of an intervention, namely its ability
to reduce the symptoms being targeted and thus improve the
overall quality of life of the client, has been labeled clinical
significance (Jacobson, Follette, and Revenstorf 1984). The
use of measures of clinical significance has increased
dramatically and has greatly improved the ability of
researchers to evaluate and compare treatments. For
example, the Jacobson and Truax (1991) method (JT) of eval-
uating clinical significance, where the interest is in determin-
ing whether the treated clients have experienced meaningful
change and whether this change has improved their standing
relative to a clinical or normal comparison group, has become
very popular and provides valuable information that cannot be
obtained from a global statistical test of pre-treatment to post-
treatment mean change (even if the change is evaluated rela-
tive to a control group) (Bauer, Lambert, and Nielsen 2004). A
noteworthy distinction in terms of the use of measures of
clinical significance is whether the interest is in evaluating
clinical significance at the individual level (i.e., determining
whether the intervention has had an important effect on each
client separately) or at the group level (i.e., dealing with the
treated group as a whole, and asking whether the intervention
has had an important effect).
Many of the popular measures of clinical significance (e.g.,
JT) initially assess clients at the individual level, although
group-level summaries of the results are a natural extension
of individual level information. Thus, although the intended
goal was to see the different ways in which individual subjects
responded to the treatment, readers of clinical research studies,
who normally have no relationship to the clients in the study,
are rarely interested in individual measures of clinical
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significance and instead are interested in some form of sum-
mary of the individual-level statistics. These summary statis-
tics can be obtained from the individual level clinical signifi-
cance statistics (e.g., proportions of clients who improved) or
can be derived from methods using the group level data (e.g.,
posttest means of the intervention group). An example of a
procedure that uses the group level data is the normative com-
parisons approach (NC) proposed by Kendall, Marrs-Garcia,
Nath and Sheldrick (1999) that compares posttest means to
normative sample means.
The purpose of this paper is to investigate the different
ways in which clinical researchers are summarizing group-
level clinical significance statistics. More specifically, this
study explores how researchers use the JT and NC methods
to make summary statements regarding the effectiveness of an
intervention. The JT method was selected because it is not
only the most popular, but also the most recommended, ap-
proach for conducting clinical significance statistics (e.g.,
Atkins, Bedics, McGlinchey, and Beauchaine 2005; Maassen
2000). The NC method was selected because it provides a
theoretically distinct approach to assessing group-level clini-
cal significance; instead of starting with individual level clin-
ical significance information the procedure directly compares
the treated group to a normal comparison group. To begin, an
introduction to the JT and NC methods will be provided.
Second, a review of treatment studies that have adopted the
JT or NC methods will be conducted in order to better
understand how these methods are being used to summarize
the clinical significance of interventions. Lastly, the results of
the review will be discussed in conjunction with
recommendations for quantifying group level clinical
significance.
Jacobson and Truax Method of Assessing Clinical
Significance
Jacobson and Truax (1991) define clinically significant
change as change that brings the client’s level of functioning
closer to the ‘functional’ population. In order to quantify how
the level of functioning can be closer to normal, JT cite three
potential cut-off points for clinically significant change: 1) the
post-treatment score lies at least two standard deviations away
from the ‘dyfunctional’ mean (labeled cutoff A); 2) the post-
treatment score lies within two standard deviations of the
‘functional’ mean (labeled cutoff B); or 3) the post-treatment
score lies closer to the mean of the ‘functional’ population
than the mean of the ‘dysfunctional’ population (labeled cut-
off C) (Jacobson and Truax 1991; Ogles, Lunnen, and
Bonesteel 2001). Cutoff A can be established using published
dysfunctional means, or by using sample measures of central
tendency (i.e., pretest scores on the measure of interest) to
represent the population parameters (although the latter is
more common). Cutoff B requires access to a normal compar-
ison group (or at least the mean of a normal comparison
group), which, preferably, is similar demographically to the
clinical sample. This could be from published information or
data collected on a normal comparison group used in the
study. Cutoff C requires both a ‘functional’ and ‘dysfunction-
al’ population, and is often preferable if this information is
available since it uses information from both populations
and thus allows for a more precise estimate of which popula-
tion the individual belongs to. JT also present a ‘reliable
change index’ (RCI) that determines whether the standardized
change from pretest to posttest for each individual can be
considered statistically significant. The RCI is designed to
ensure that a post-test score that crosses the ‘functional’ cut-
off point is indeed statistically reliable. The RCI is calculated
as:
RCI ¼ X post−X pre
sdiff
Here Xpre represents a client’s pretest score,Xpost represents
that same client’s posttest score, and Sdiff is the standard error
of difference between the two test scores. Although there have
been several alternative and modified JT methods that have
been proposed (e.g., Hageman and Arrindell 1999; Hsu 1999;
Speer 1992; Speer and Greenbaum 1995), the original method
remains the most popular (Bauer, Lambert, and Nielsen 2004),
and is often recommended because it provides clinical signif-
icance results that are asymptotically equivalent to the modi-
fied procedures and does not require (possibly inaccurate)
estimates of unknown population parameters.
As the JTstatistics initially evaluate clients at the individual
level, an important question that arises is how researchers
conducting JT analyses summarize the RCI and cut-point re-
sults across all clients receiving a particular intervention in
order to gain a more thorough understanding of the practical
value of that intervention at the group level (for a detailed
discussion of using individual level data to make group level
statements see Cella, Bullinger, Scott, and Barofsky 2002). An
obvious choice would be to simply compute proportions for
each possible outcome from the RCI and cut-point results. For
example, a researcher could calculate the proportion of clients
who are recovered (i.e., met RCI and cut-point cut-offs), im-
proved (met RCI but not cut-point cut-offs), deteriorated (met
RCI cut-point but in the wrong direction), or unchanged (did
not meet RCI or cut-point cut-offs). However, more sophisti-
cated analyses could be conducted by comparing proportions
(e.g., comparing category proportions for a single intervention
or comparing category proportions for one intervention to
those for a control group or another intervention group). In
the study, we will identify and quantify the use of different
methods for summarizing individual level clinical signifi-
cance data.
Curr Psychol (2015) 34:672–680 673
Kendall et al. Method of Assessing Group Level
Clinical Significance
Kendall et al.’s (1999) NC method approaches the problem of
measuring clinical significance from a very different angle
than the previously discussed individual level statistics. In-
stead of initially summarizing the data at the individual level
(e.g., RCIs for each client), the group (i.e., intervention) level
posttest means are computed and compared to a similar nor-
mal comparison group on the outcome variable of interest
(e.g., depression, perfectionism). More specifically, the NC
method assesses whether the treated clinical group is equiva-
lent to a normal comparison group. An important advantage of
the NC method is that it directly assesses the question of
whether the intervention being investigated is able to return
clients to a state of normal functioning. Kendall et al. accom-
plished the goal of assessing the equivalence of the treated and
normal comparison groups by incorporating the equivalence
testing methods proposed originally in the field of
biopharmaceuticals (e.g., Schuirmann 1987; Westlake 1981)
and introduced to psychology by Rogers, Howard and Vessey
(1993), Seaman and Serlin (1998), and others. Unlike tradi-
tional null hypothesis test procedures that are designed to in-
vestigate a difference in population parameters (e.g., means),
equivalence testing methods are designed to investigate the
statistical equivalence of population parameters. With regard
to the statistical equivalence of group means, equivalence test-
ing methods, more specifically, seek to answer the question of
whether the difference in means (e.g., differences in the treat-
ed and normal comparison means) is so small that it can be
considered inconsequential. The amount of difference that is
considered inconsequential is called the equivalence bound
(δ) and is usually symmetric (i.e., the equivalence interval
spans from −δ to δ). This bound is an important part of equiv-
alence testing and needs to be selected based on the specific
nature of each study. For detailed discussions of setting this
bound see Rogers et al. or Cribbie and Arpin-Cribbie (2009).
In terms of understanding the difference between tradition-
al and equivalence tests, recall that with traditional methods
(e.g., t or F test) the research hypothesis relates to difference
and thus the alternative hypothesis (Ha: μ1≠μ2 for a two-tailed
test) appropriately also relates to difference, whereas for
equivalence tests the research hypothesis relates to equiva-
lence and thus the alternative hypothesis (Ha: −δ≤μ1
−μ2≤δ) also appropriately relates to equivalence. Although
it might be tempting to assess the equivalence of the treated
and normal comparison means by looking for nonsignificance
with a traditional difference-based test (e.g., t test) this would
not be appropriate because, as any introductory statistics text-
book teaches us, not rejecting Ho: μ1=μ2 cannot be used to
conclude that the population means are equal.
Kendall et al. (1999) proposed assessing the equivalence
of the treated and normal comparison groups using the two
one-sided tests (TOST) approach due to Schuirmann
(1987). With this method, two null hypotheses are tested,
error for the traditional t test, respectively. Cribbie and
Arpin-Cribbie (2009) proposed the use of the
heteroscedastic Schuirmann-Welch statistic (Gruman,
Cribbie, and Arpin-Cribbie 2007), instead of the original
Schuirmann statistic, in order to account for the often un-
equal variances (and sample sizes) of the treated and nor-
mal comparison groups, which biases the original
Schuirmann test.
The purpose of the present paper is to determine the man-
ner in which researchers are summarizing the clinical signifi-
cance of interventions at the group level. In order to examine
this issue, two literature reviews will be conducted. The first
literature review evaluates how researchers are summarizing
the results of individual level JT analyses (RCI, cutoffs). The
second literature review investigates the frequency and nature
of use of the NC approach. Together, these reviews are
intended to provide information regarding current practices
for assessing clinical significance at the group level. It is im-
portant to point out that this study is not intended to be a meta-
analysis of the clinical effects; it was felt that these added
results would only detract from the primary purpose of explor-
ing the manner in which the analyses were conducted by turn-
ing the attention of readers to the study outcomes. However, a
summary of the results of the clinical significance assessments
for each study is available by contacting the first author.
Method
Literature Review 1: JT Method
A review of intervention studies that utilized the JT method
was conducted in order to determine the manner in which
individual level JT statistics (RCI, normative cutoff analyses)
are being used to determine the clinical significance of specif-
ic interventions (i.e., group level analyses). TheGoogle Schol-
ar database was used to gather studies for this review. It is
important to point out that the results returned from Google
Scholar and PsycINFO were very similar, and thus we chose
Google Scholar for its ease of access and replicability. Studies
were included if they were peer-review journal articles pub-
lished in 2010 or 2011, with the search requiring studies to
have one of ‘treatment’, ‘intervention’ or ‘therapy’ in the title.
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Ho1: μT - μNC≤-δ and Ho2: μT - μNC≥δ, where μT repre-
sents the population mean of the treated population and
μNC represents the population mean of the normal compar-
ison population. Ho1 is rejected if t1≤ tα,ν and Ho2 is
rejected if t2≥t1−α,ν, where t1=[MT - MNC - δ] / sMT-MNC,
t2=[MT - MNC - (-δ)] / sMt-MNC, α represents the nominal
significance level, M represents the sample mean, and ν
and sM1-M2 represent the degrees of freedom and standard
The search was limited to 2010 and 2011 because that time
frame provided us with our target number of articles (150,
which was deemed by the authors to provide an optimal bal-
ance between precision and time). Further, the article needed
to reference the original Jacobson and Truax (1991) manu-
script. Using these search criteria, 194 articles were identified.
Thirty two articles were excluded because an intervention was
not conducted, did not use the JT method or were not pub-
lished journal articles (e.g., dissertations), leaving 162 articles
that met inclusion criteria. The following information was
extracted from the articles: 1) primary outcome variable; 2)
type of intervention; 3) result of the statistical significance of
the pre-post change (either raw or relative to a control group);
4) use or nonuse of the RCI statistic; 5) use or nonuse of a
cutoff for moving closer to the functional population; 6) if a
cutoff was adopted, which cutoff was applied; 7) method of
summarizing the individual level statistics; and 8) inclusion/
non-inclusion of an effect size if a summary statistic was uti-
lized. Although Ronk, Hooke and Page (2012) highlight the
importance of the selection of an appropriate outcome mea-
sure when conducting clinical significance analyses, given the
wide variety of treatment outcomes and treatment outcome
measures, we limited our investigation to only the primary
outcome measure in each study.
Literature Review 2: NC Method
A review of intervention studies that utilized the NC method
was conducted in order to determine the frequency and man-
ner in which NC analyses are being applied to summarize
group-level clinical significance. The Google Scholar data-
base was also used to gather studies for this review (and again
the results were very similar to those obtained using
PsycINFO). The studies were obtained from the years 2000–
2011, with the search requiring studies to be intervention stud-
ies published in peer reviewed journals with one of ‘treat-
ment’, ‘intervention’ or ‘therapy’ in the title, and further that
the article referenced the original Kendall et al. (1999) manu-
script. It was necessary to include more years for the NC
review than the JT review since there were fewer articles
available that referenced the NC methodology than the JT
methodology. This search resulted in 83 papers. Sixty articles
were excluded because the authors did not utilize the Kendall
et al. NC method and 11 studies were excluded because the
authors used the NC method incorrectly. This resulted in 12
articles that met the inclusion criteria of appropriately using
the NC method. The following information was extracted
from these articles: 1) primary outcome variable; 2) type of
intervention(s); 3) result of the statistical significance of the
pre-post change (either raw or relative to a control group); 4)
nature of the normative sample; 5) nature of the equivalence
interval; 6) test statistic used for the NC analysis; and 7) result
of NC analysis.
Results
JT Method Review Results
The results of the JT review are summarized in Table 1. It was
found that of the 162 studies that met inclusion criteria, the
median sample size was 36 for the primary intervention group,
about a quarter of the studies used a control group, a third
conducted some form of cognitive behavioral therapy (only
three studies used non-psychological forms of intervention,
e.g., pharmacological), and most (87 %) had a significant
intervention effect. Further, the most common primary out-
come variables were mood-related (e.g., depression, hopeless-
ness; 22 %) and anxiety-related (e.g., generalized anxiety,
post-traumatic stress, social phobia; 35 %), with many other
outcomes including addictive behavior, eating disorder-
related behavior, etc. accounting for the remaining 43%. Note
that this remaining 43 % also includes outcomes such as
“well-being” which could cross many categories including
the anxiety-related and mood-related categories above. As ex-
pected given the search criteria, almost all conducted individ-
ual level clinical significance analyses. Further, almost all
studies also conducted some form of group level clinical sig-
nificance analyses. For the individual level tests, the most
frequently used cutoff was A (relative to the mean of the
dysfunctional population), which is not surprising given that
this is probably the easiest method for which to obtain a com-
parison level (e.g., using published clinical means or using the
existing pre-intervention means) since normative data is often
not available (Jacobson and Truax 1991).
For conducting the group level analyses, about an equal
number of studies used both RCI and cutoff information and
RCI information alone. Less than 10% of studies solely relied
on whether the client met normative cutoffs to summarize the
group level analyses. About three-quarters of the group level
analyses simply summarized the proportion of clients who
improved, deteriorated, etc. However, 15 % of studies com-
pared the proportions across treatment groups (or across treat-
ment and control groups) using, for example, a χ2 test of
independence. Four studies (3 %) compared the proportion
of clients that met each standard within only the treatment
group (e.g., conducted a χ2 goodness of fit test).
NC Method Review Results
The results of the NC review are summarized in Table 2.What
is initially interesting is that about an equal number of studies
correctly and incorrectly adopted the Kendall et al. (1999) NC
method. The primary fault in applying the NC method was
that the researchers did not conduct an equivalence test, the
primary test necessary for concluding whether the treated pop-
ulation is equivalent to the normal comparison population.
This finding may not be surprising given that equivalence
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testing methods are relatively novel and not available with
most statistical software packages, however it definitely high-
lights the need for more coverage in the literature on the ap-
propriate use of the NC method. Of the studies that correctly
used the NC method, the median sample size was 30 for the
primary intervention group, most (83 %) used some form of
cognitive behavioral therapy (all interventions were
psychological in nature), two thirds had anxiety as the primary
outcome, almost all had a significant intervention effect, and
slightly less than half had a control group. However, we cau-
tion that these numbers are based on a very small set of articles
and thus it is important to not read too much into the specific
proportions. The normative sample descriptive statistics used
in these studies were all derived from previously published
Table 1 Conclusions from the
Jacobson-Truax (JT) review study Review item Results
Total Number of Studiesa 162
Mean, Median Group Sample Sizeb 134, 36
With a Control Group 26 %
With a Significant Treatment Effectc 87 %
Conducted Individual Level Clinical Significance Analyses 99 %
Conducted Group Level Clinical Significance Analyses 97 %
Used JT Cutoff A, B, C d 46 %, 14 %, 23 %
Used RCI and Cutoffs for Group Level Test 49 %
Used only RCI for Group Level Test 42 %
Used only JT Cutoffs for Group Level Test 9 %
Group Level Test based only on Proportions 80 %
Group Level Test based on Between-Group Chi-Square Test 15 %
Group Level Test based on Within-Group Chi-Square Test 3 %
If Chi-square Conducted, % Including an Effect Size 7 %
a Studies that applied the JT method
b Based on the primary treatment group
c Significant change, or significant change relative to control group
d Of studies that used a cutoff and the cutoff used could be determined; one study used both cutoffs A and C
RCI reliable change index




Total Number of Studies that Purported to use the NC Approach 23
Number of Studies that Correctly used the NC Approacha 12
Number of Studies that used the NC Approach Incorrectlyb 11
Mean, Median Group Sample Sizec 79, 30
Mean, Median Normative Sample Size 907, 233
With a Control Group 42 %
With a Significant Treatment Effectd 92 %
Used Schuirmann’s Two One-Sided Test Proceduree 100 %
Used 1 sd, 2 sd from the Normative Mean as δf 86 %, 14 %
Treated sample declared equivalent to normative sample 50 %
Studies using published normative datag 100 %
a Studies that correctly applied the equivalence-based normative comparisons approach
b These studies were not used to calculate any of the statistics below
c Based on the primary treatment group
d Significant change, or significant change relative to control group
eOne study did not indicate which test was used and thus was excluded from this calculation
f Five studies did not indicate what equivalence interval was used
g Instead of collecting normative data that was representative of the treated sample; two studies did not provide
information regarding the nature of the normative sample and were excluded from this calculation
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studies (i.e., none collected the normative data), and the me-
dian sample size of these studies was 233. All of these studies
used Schuirmann’s two one-sided test procedure (the proce-
dure described in the original Kendall et al. article) and all but
one used one standard deviation of the normative sample as
the equivalence interval. Half of the studies found that the
intervention group following treatment could be considered
equivalent to a normal comparison group.
Discussion and Recommendations
As was expected, almost all studies conducted some sort of
group level summary, with many more studies utilizing the JT
method (162 studies used the JT method over just a 2 year
period) than the NC method (only 12 studies correctly used
the NCmethod over an 11 year period). An interesting finding
is that across both reviews (JT/NC) less than 30 % of studies
had a control group. This is very serious given that statistical
analyses investigating change over time as a function of the
interventions can be very misleading when they are not con-
ducted relative to a control group (due to regression to the
mean, placebo/waitlist effects, etc.).
Although most of the studies that adopted the JT method
provided a straightforward summary of howmany people met
predetermined cutoffs (e.g., how many changed reliably and
met criteria for moving towards normal functioning, i.e., were
‘recovered’), there are some important points regarding how
these summaries were obtained and what follow-up tests are
available. First, most researchers (83 %) that used cutoffs used
one of the cutoffs suggested by Jacobson and Truax (1991),
namely falls outside the dysfunctional range (A), falls within
the normative range (B), or falls closer to the mean of the
normative population (C) (one study used both cutoffs A
and C). As Kazdin (1999) discusses, it is important to consider
what cutoff provides the best balance between specificity and
sensitivity (i.e., correctly classifying recovered clients and not
recovered clients). As an introduction to the problem,
Jacobson and Truax explain that when norms are available B
or C are recommended, with C preferable when the functional
and dysfunctional populations overlap, and B preferable when
the distributions do not overlap (when normative data is not
available, A is the only cutoff available). It is a little discon-
certing that almost half of the studies used cutoff A, given the
preference in the literature for cutoff C (e.g., Jacobson and
Truax 1991; Bauer et al. 2004) since most distributions over-
lap. The preference for cutoff A may relate to the fact that
normative data is relatively scarce for many measures and
most studies did not have a control group. It is important
though that researchers acknowledge that clinical and norma-
tive statistics are available for many common psychological
measures, and the incorporation of this information will allow
for potentially more meaningful comparisons (e.g., use of
Cutoff C). Very few studies had any discussion of how the
particular cutoff used was selected, and thus we recommend
that researchers consider what the most appropriate cutoff
might be that maximizes sensitivity and specificity.
Secondly, less than 20 % of the studies compared the pro-
portions in each category (e.g., using a chi-square test), and
only 7 % of those that statistically compared proportions in-
cluded an effect size. Although the chi-square test can simpli-
fy the reporting of group level statistics, it is important that
these analyses are conducted in a logical manner. For exam-
ple, imagine that for the treatment group 30 % were ‘recov-
ered’, 40 % ‘improved’, 20 % were ‘unchanged’ and 10 %
‘deteriorated’, and for the control group 30 % were ‘recov-
ered’, 40 % ‘improved’, 1 % were ‘unchanged’, and 29 %
deteriorated. If a researcher were to run a chi-square test of
independence on this data, the conclusion would likely be a
significant effect indicating that the proportions differ across
the categories. However, in this instance, it is clear that this
result is only indicating a difference in the number of clients
who were ‘unchanged’ or ‘deteriorated’ (a result that may be
of different importance or relevance to a researcher).
Thus, there are a few recommendations regarding using
group-level comparisons of proportions following JT (or sim-
ilar) methods: 1) Follow-up tests comparing groups across all
categories would be meaningful and would add important
information. For example, if there was a control group, com-
paring the proportion of ‘recovered’, ‘improved’, ‘un-
changed’, and ‘deteriorated’ clients across the treatment and
control group would be very informative. If there was not a
control group, comparing these categories across the treated
group would also add useful information. 2) Related to the
first point, specific comparisons would provide more precise
information about the nature of the effect than a global test of
independence. For example, comparing those improved/
recovered to those unchanged/deteriorated in the treatment
and control groups using a 2×2 chi-square test of indepen-
dence (or just the treatment group using a chi-square goodness
of fit test), would provide more specific information about
how the treatment response differed across groups. 3) Effect
sizemeasures applied tomeaningful comparisons (such as that
proposed in the previous point) would be recommended as
complements to traditional null hypothesis testing methods
(such as those proposed in the previous two points) because
we do not want the sample size of the study to have such a
large influence on the calculation of the practical significance
of the intervention (Wilkinson et al. 1999). Examples of infor-
mative effect size measures are odds ratios and correlation-
based measures such as Cramer’s V. 4) Lastly, the JT method
assumes normal distributions when establishing cutoff points
and the RCI, and thus researchers should be aware of the
potential effects of nonnormality. In their paper, Jacobson
and Truax concede that such an assumption is a problem that
limits the generalizability of their method. This is important
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since nonnormality is frequently encountered with psycholog-
ical variables (Golinski and Cribbie 2009; Micceri 1989; van
Wieringen and Cribbie 2014).
An alternative approach for summarizing the clinical sig-
nificance of an intervention at the group level is to ask whether
the treated group is equivalent to a normal comparison group
following the intervention. For example, the NC method pro-
posed by Kendall et al. (1999) uses equivalence testing to
determine if the treated group can be considered statistically
equivalent to a normal comparison following the treatment. Of
the 23 studies that purported to adopt this method, only about
one-half actually conducted the method accurately. In most
cases where the method was applied incorrectly, the re-
searchers did not use an equivalence test to actually compare
the treated and normal comparison groups; for example, some
simply determined the proportion of clients that fell close to
(e.g., one sd from) the normative mean (i.e., a sort of modified
JT method). Of those that correctly used the method, all used
the Schuirmann (1987) two one-sided testing approach for
assessing the equivalence of the treated and normal compari-
son groups. One concern with the use of this method is that it
is not robust to unequal sample sizes and variances (Cribbie
and Arpin-Cribbie 2009; Gruman, Cribbie, and Arpin-Cribbie
2007). This is especially problematic given that the group
sizes and standard deviations of normal comparison and treat-
ed clinical groups often differ substantially. For example, the
median sample size of the clinical groups was 30, whereas the
median sample size of the normal comparison group was 233.
Since methods exist that do not rely on the assumption of
variance homogeneity (e.g., Gruman et al. 2007; Koh and
Cribbie 2013), there is no reason to rely on outdated
approaches.
Further, given past studies that have found that the distri-
butions of variables in psychology are often nonnormal (see
above), it is also important to use a test statistic that is robust to
violations of the normality assumption. Robust tests for eval-
uating the equivalence of independent groups have been
discussed by Gruman, Cribbie and Arpin-Cribbie (2007),
Cribbie and Arpin-Cribbie (2009), Koh and Cribbie (2013),
van Wieringen and Cribbie (2014), among others, and are
recommended over the original Schuirmann procedure since
it is expected that the assumptions of variance homogeneity
and/or normality will be violated across clinical and normal
comparison groups.
Another concern with the studies that adopted the NC
method was that all used published normative data instead
of collecting normative data that was more representative of
the clinical sample. In some cases it is possible to find a nor-
mative sample that is somewhat representative of the charac-
teristics of the clinical sample, however inmany cases this will
not be the case. As expected, comparing groups that differ in
ways other than just having or not having the clinical disorder
of interest (e.g., differing in age, culture, education, etc.)
severely limits the validity of the equivalence-based test.
Thus, although it can be time consuming, in some situations
it is necessary for researchers to collect representative norma-
tive data in order to ensure that the comparisons conducted are
meaningful.
Lastly, most studies used an equivalence bound of one
standard deviation (of either the control or clinical group)
when conducting the test of equivalence. Although this has
become standard practice following its use by Kendall et al.
(1999) in their examples, it is important, as Kendall et al.,
Rogers, Howard and Vessey (1993), and others, highlight, that
the equivalence interval is tailored to the specific nature and
goals of the study.
Before concluding, it is important to consider potential
limitations of the study. First, we used a specific set of search
criteria for finding articles for this review. It is possible that a
different set of criteria may have uncovered more or different
articles than we found, and this could potentially have affected
the results and conclusions. Second, and related to the first
limitation, is that the number of articles found that correctly
utilized the NC method was very low. Thus, we caution the
reader about making any general conclusions regarding the
manner in which the NC method is being used in practice.
As use of the relatively new method increases, much more
reliable results based on a larger set of articles will be avail-
able. Third, we have only considered two methods for
assessing group-level clinical significance; specifically, we
have considered two popular statistical approaches for sum-
marizing group level clinical significance. Further, these
methods generally use popular scales/questionnaires to mea-
sure the behavior of interest. However, the degree to which
changes in scores on a specific inventory (e.g., Beck Depres-
sion Inventory) translates into real-world/everyday improve-
ments in functioning can vary from behavior to behavior. Fur-
ther research should be dedicated to studying the measure-
ment of these important behavioral changes that are (often)
more difficult to measure. For example, measuring the clients’
subjective level of functioning, assessments of functioning
from others close to the client (Cella et al. 2002), including
assessments related to functioning in occupational or other life
activities, may prove to be a valuable tool for understanding
clinical significance at the group level. Lastly, and not neces-
sarily a limitation of the study but of the incorporation of the
methods discussed in the study, is the difficult task of finding
an appropriate normal comparison group and measurement
instrument. There has been a lot of discussion surrounding
what constitutes an appropriate normal comparison group
(e.g., Rogers et al. 1993), however many issues still exist.
For example, as an anonymous reviewer of this paper asked,
is it appropriate to compare a clinical group to a normal group
that contains individuals who would meet the criteria for the
clinical group or are even actively involved in treatment. Once
the definition of an appropriate normal comparison group is
678 Curr Psychol (2015) 34:672–680
established, an even more difficult task might be to find data
for this group. Many researchers have highlighted the paucity
of normal comparison data for popular scales in the literature,
and collecting valid normal comparison data is often beyond
the scope of most investigations. Further, in some cases the
scales may not have been validated on normal comparison
groups and there are questions regarding the appropriateness
of the scale for use with a normal comparison population. A
related issue is whether there is a linear relationship between
scale scores and the level of pathology.
To summarize, this study looked at two common ap-
proaches for summarizing the group level effect of an inter-
vention. One strategy explores (and/or compares) the propor-
tion of subjects that reliably changed and met cutoffs for mov-
ing towards normal functioning (JT method), while the other
assesses whether the treated group is equivalent to a normal
comparison group following the intervention (NC method).
While these are effective and highly recommended strategies
for addressing different questions regarding the clinical signif-
icance of an intervention, the validity of both approaches re-
lies to a great extent on the methodology used. Our primary
recommendation is that researchers carefully ponder what
measure of clinical significance is most appropriate for their
given research. The JT method more directly incorporates
individual results; however, the importance of selecting an
appropriate cutoff for determining if the client progressed to-
ward normal functioning cannot be overestimated (e.g., sim-
ply comparing the treated sample to their pretest mean may
not be an appropriate contrast). The NC method more directly
assesses whether the treated group has been returned to a state
of normal functioning, however individual results have less
impact, it can often be difficult to obtain appropriate normal
comparison data, and it is important that researchers adopt an
appropriate test statistic given the frequent violations of para-
metric test assumptions. It should be clear that numerous fac-
tors much be considered in order to ensure reliable and valid
information regarding group-level clinical significance.
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